Definitive Contract 75N91024C00098
Award Date 9/12/24
Potential Completion Date 9/11/26
Potential Value $2M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Worcester, MA 01605, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This is a Firm Fixed Price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Spatial Surgical LLC, a for-profit limited liability company, for $398,625. The contract is for the research and development of an "Integrated Cell Culture Chamber and Flow Guide for POC, Walk-Away Operation for Autologous T Cell Manufacturing". This aligns with the NCI's mission to support innovative medical technologies and cell-based therapies. The contract has a total small business...
- This is a $1,997,803 firm fixed-price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Cell Microsystems Inc., a small business manufacturer of specialized biomedical research equipment and tools. The contract is for the topic "Integrated Imaging and Molecular Analysis of Glioblastoma Using SCOPE SEQ on the Air Flow" and has a total small business set-aside designation. The contract will support...
- <p>This SBIR Phase I contract was awarded by the National Cancer Institute (NCI), a civilian federal agency, to Transgenex Nanobiotech Inc., a minority-owned small business, for the development of a "fibrous scaffold-induced spheroids mimicking TME" solution. The contract, valued at $299,992.00, is a definitive, firm fixed-price contract with a completion date of July 21, 2014. The contract was set aside for the participation of small businesses.</p>
- This is a $399,062 firm-fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Avoneaux Medical Institute, LLC for the development of spatial micro-purification technology. The contract was set aside for small businesses and is part of the NCI's broader SBIR program, which funds research and development in support of the NIH and CDC's mission needs. The original solicitation sought proposals on a range of cancer-related topics, including alternatives to cell...
- This is a Firm Fixed Price contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Cell Microsystems Inc., a small business manufacturer of tools for imaging, sorting, and isolating single cells and colonies. The $2,295,432.00 contract, which is part of the Small Business Innovation Research (SBIR) program, supports the integration of Cell Microsystems' SCOPE SEQ technology with air flow capabilities for the molecular analysis of glioblastoma, an aggressive...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
- This is a $3,500,000.00 Phase II Small Business Innovation Research (SBIR) contract awarded by the Advanced Research Projects Agency for Health (ARPA-H), a component of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to Optosurgical, LLC, a small business based in Columbia, Maryland. The contract is for the development of an "Advanced Imaging Aided Autonomous Robotic Cholecystectomy" system, which involves the use of robotics and advanced...
- This is a $225,000.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian agency, to Transgenex Nanobiotech Inc., a Minority Owned, For Profit, Subcontinent Asian (Asian-Indian) American Owned business. The contract is for "SBIR PHASE I - FISS-CSC: A FIBER-INSPIRED SMART SCAFFOLD PLATFORM FOR EXPANDING CANCER STEM CELLS" and was awarded on September 22, 2015 with a completion date of August 21, 2016. This appears to be a Small Business Innovation Research...
- <p>This is a $1,999,386.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Avoneaux Medical Institute, LLC, a veteran-owned limited liability company. The contract is for the development of spatial micropurification technology under SBIR Topic 403. The contract is a definitive, firm fixed-price contract with a period of performance ending on September 18, 2024.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Celartia, Inc., a small disadvantaged business, for the development of a fully automated system for cell therapy processing. The contract has a period of performance from September 13, 2021 to June 12, 2022 and a ceiling value of $393,312. The contract was awarded under a total small business set-aside. The original...